HL

Haleon PLC (HLN)

HealthcareDrug Manufacturers - Specialty & Generic
333.80GBX
-0.27%
Magic Rank
#94
Earnings Yield
6.7%
Return on Capital
> 999%
Cap. Boursière
29.6B

Performance vs S&P 500 (5 ans)

HLN.LSE
S&P 500

À propos Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Analyse Magic Formula

Valeur d'Entreprise36.8B
Marché / Univers
gb
Royaume-Uni

"Une entreprise avec un ROC élevé et un EY élevé a statistiquement plus de chances de surperformer le marché."

Indicateurs Clés

P/E Ratio17.58
Rendement dividende2.1%
Dette / Fonds propres0.44
Marge Brute23.2%